DNA microarray screening of differential gene expression in bone marrow samples from AML, non-AML patients and AML cell lines
Court, E., Smith, M. A., Avent, N. D., Hancock, J. T., Morgan, L., Gray, A. and Smith, J. G. (2003) DNA microarray screening of differential gene expression in bone marrow samples from AML, non-AML patients and AML cell lines. Leukemia Research, 28 (7). pp. 743-753. ISSN 0145-2126 Available from: http://eprints.uwe.ac.uk/8321
Full text not available from this repository
Publisher's URL: http://dx.doi.org/10.1016/j.leukres.2003.11.011
This study used cDNA microarray technology to compare gene expression profiles in acute myeloblastic leukaemia (AML) with cDNA dot-blot and real time PCR analysis of cDNA transcripts to confirm array data. Patient AML marrow samples and AML cell lines were compared with normal/non-AML samples. Screening revealed five particular genes to be significantly differentially expressed across the sample groups. The migration-inhibitory factor-related-proteins 8 and 14 (MRP-8 and MRP-14) genes, the products of which inhibit cell migration and differentiation were the most highly expressed in non-malignant cells. The high-mobility-group-protein gene (HMG-1) was up regulated in leukaemic samples and cell lines, which may be associated with aggressive disease. Also upregulated in malignant samples were genes encoding c-myc and glutathione−S−transferase pi (GSTP), the latter implicated in chemotherapy resistance. Faulty expression of such genes may contribute to the pathogenesis of AML and resistance to treatment.